Mylan's Copaxone Suit Against Teva Should Survive, Judge Says
Teva Pharmaceutical Industries Ltd.'s bid to dismiss antitrust claims should be denied in a case where Mylan Pharmaceuticals Inc. alleges the company unlawfully delayed a generic version of a multiple ...
ICLR STOCK NEWS: ICON plc Investors are Reminded to Contact BFA Law about the Pending Class Action before the April 11 Deadline
New York, New York-- (Newsfile Corp. - March 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain of ...
SHCO STOCK NEWS: Soho House & Co. Investors are Reminded to Contact BFA Law about the Pending Investigation into the Acquisition Offer
New York, New York-- (Newsfile Corp. - March 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Soho House & Co. Inc. (NYSE: SHCO), the board of ...
Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds
Amphastar's Q4 sales grew 20% to $186.5M, missing estimates. Primatene MIST surpassed $100M in annual sales, while Baqsimi saw strong growth.
S&P 500 February winners, losers as stock benchmark ends monthly journey in the red
The S&P 500 (SP500) hit new highs during February trade, but that wasn’t enough to stave off a monthly loss. The benchmark ...
PharmiWeb13h
Global Generic Oncology Drugs Market Poised for Steady Growth, Projected to Reach USD 30,606.3 Million by 2035
The global generic oncology drugs market is set for consistent growth over the next decade, with sales anticipated to rise from USD 23,743.5 million in 2025 to USD 30,606.3 million by 2035, reflecting ...
Future Market Insights14h
Global Seasonal Affective Disorder Therapeutics Market Poised to Reach USD 1,466.2 Million by 2035, Driven by Growing Mental Health Awareness | FMI
The global seasonal affective disorder therapeutics market is set for steady growth, with revenue projected to reach USD ...